Crawford_1982_J.Biol.Chem_257_3853

The newly developed monoclonal antibody technology was applied to the production of antibodies selective for Drosophila melanogaster choline acetyltransferase (EC 2.3.1.6). Two stable cell lines, 1C8 and 1G4, were isolated from NS-1/spleen cell hybrids by employing a choline acetyltransferase enzyme activity-screening method. Both cell lines were cloned twice and were maintained in continuous culture and as ascites tumors. Purified antibody was isolated from ascites fluids by pH elution after adsorption to Protein A-Sepharose. Both antibodies eluted from the Protein A-Sepharose as a single subclass, IgG1, and directly inhibited choline acetyltransferase activity. Scatchard analysis of titration data for choline acetyltransferase antibody-enzyme interaction generated linear curves for both antibodies: KA for 1C8 was 2.77 X 10(7) M-1 and KA for 1G4 was 0.78 X 10(7) M-1. Inclusion of the choline acetyltransferase substrate acetyl-CoA at 10 times the KM in the antibody-enzyme reaction mixture substantially reduced the level of inhibition observed with both antibodies; choline, however, exhibited no protective effect. Neither antibody reacted with choline acetyltransferase-containing extracts of vertebrates or other insect neural tissues. We conclude that the two antibodies are nonidentical, monoclonal, and highly selective for D. melanogaster choline acetyltransferase, both reacting at or near the acetyl-CoA binding region of the enzyme-active site.